Close Menu

NEW YORK – Medical technology company Cytovale announced Thursday it has received an additional $3.8 million to fund a pilot study for its rapid sepsis diagnostic system for patients with respiratory infections.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.